Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients
Affiliated Hospital of Nantong University
Affiliated Hospital of Nantong University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University Medical Center Groningen
University Health Network, Toronto
University Hospital, Ghent
University Hospital Rijeka
Assiut University
Xijing Hospital
Guangdong Provincial People's Hospital
University of Cologne
UMC Utrecht
Pamukkale University
Peter MacCallum Cancer Centre, Australia
Jiangsu Cancer Institute & Hospital
University Hospital, Ghent
University Hospital, Linkoeping
Universidad de Granada
University Hospital Augsburg
Consorzio Oncotech
National Cancer Institute, Naples
Direction Centrale du Service de Santé des Armées
Instituto Venezolano de Investigaciones Cientificas
Hôpital Franco-Britannique-Fondation Cognacq-Jay
University of Kansas Medical Center
Sichuan Cancer Hospital and Research Institute
Elisabeth-TweeSteden Ziekenhuis
Chinese PLA General Hospital
Peking Union Medical College Hospital
Seoul National University Hospital
Maastricht University Medical Center
Maastricht University Medical Center
Institut Cancerologie de l'Ouest
Zhongnan Hospital
Tianjin Medical University General Hospital
Asan Medical Center
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Peking Union Medical College Hospital
Valley Health System
Fondazione del Piemonte per l'Oncologia
Peking Union Medical College Hospital
Post Graduate Institute of Medical Education and Research, Chandigarh
Grupo Espanol de Investigacion en Sarcomas
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Jiangxi Provincial Cancer Hospital
Institut Bergonié
Chang Gung Memorial Hospital
Institut Cancerologie de l'Ouest
Sykehuset i Vestfold HF
Sykehuset i Vestfold HF
California Pacific Medical Center Research Institute